|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 48/00 | |
| C12N 15/864 | |||
| C12N 9/64 |
| (11) | Patento numeris | 2438931 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 12150318.9 |
| Europos patento paraiškos padavimo data | 2005-09-09 | |
| (97) | Europos patento paraiškos paskelbimo data | 2012-04-11 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2013-11-13 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (30) | Numeris | Data | Šalis |
| 612135 P | 2004-09-22 | US |
| (72) |
Gray, John Trainor, US
|
| (73) |
St. Jude Children`s Research Hospital,
262 Danny Thomas Place, Memphis, Tennessee 38105,
US
|
| (54) | Improved expression of factor IX in gene therapy vectors |
| Improved expression of factor IX in gene therapy vectors |